Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
BCL Inhibitors
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
5
10
15
20
25
30
35
40
45
50
navitoclax
(ABT 263) / AbbVie
Genasense
(oblimersen) / Genta
R-(-)-gossypol
(AT 101) / Ascentage Pharma
Oraxol
(oral paclitaxel/encequidar) / Athenex
lisaftoclax
(APG-2575) / Ascentage Pharma
obatoclax
(GX 15-070) / Teva
Opaxio
(paclitaxel poliglumex) / SOBI
sonrotoclax
(BGB-11417) / BeiGene
Liporaxel
(paclitaxel oral) / Dae Hwa, HaiHe Biopharma
paclitaxel trevatide
(ANG1005) / Angiochem
EndoTAG-1
(paclitaxel liposomal) / Sinphar Pharma
Taxoprexin
(DHA-paclitaxel) / Daiichi Sankyo
ICP-248
/ InnoCare
Oncofid-P
(paclitaxel-hyaluronic acid conjugate) / Fidia Farmaceutici
Paclical
(micellar paclitaxel) / Vivesto, HLB Bio Group
Keaili
(albumin bound paclitaxel) / CSPC Pharma
paclitaxel micelle formulation
(NK-105) / NanoCarrier, Nippon Kayaku
